Cargando…
Levels and Clinical Significance of Regulatory B Cells and T Cells in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a heterogeneous hematological malignancy, whose immunological mechanisms are still partially uncovered. Regulatory B cells (Bregs) and CD4+ regulatory T cells (Tregs) are subgroups of immunoregulatory cells involved in modulating autoimmunity, inflammation, and transp...
Autores principales: | Dong, Qiaofeng, Li, Guosheng, Fozza, Claudio, Wang, Shuli, Yang, Shuhuan, Sang, Yuqi, Liu, Xinguang, Chen, Chunyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557919/ https://www.ncbi.nlm.nih.gov/pubmed/33083479 http://dx.doi.org/10.1155/2020/7023168 |
Ejemplares similares
-
Strabismus and diplopia in a patient with acute myeloid leukemia
por: Fozza, Claudio, et al.
Publicado: (2014) -
The Role of Regulatory B Cells in Patients with Acute Myeloid Leukemia
por: Lv, Ying, et al.
Publicado: (2019) -
A Real-World Study on Clofarabine and Cytarabine Combination in Patients with Relapsed/Refractory Acute Myeloid Leukemia
por: Crobu, Valeria, et al.
Publicado: (2019) -
Midostaurin reduces Regulatory T cells markers in Acute Myeloid Leukemia
por: Gutierrez, Lucas, et al.
Publicado: (2018) -
miRNAs in acute myeloid leukemia
por: Liao, Qiong, et al.
Publicado: (2016)